×

Quick Summary: Pennsylvania R&D Tax Credit and PIT Integration

The Pennsylvania Research and Development (R&D) Tax Credit is a statutory incentive under Article XVII-B that allows businesses and owners of pass-through entities to offset their Personal Income Tax (PIT) liability defined in Article III. By calculating Qualified Research Expenses (QREs) incurred within the Commonwealth, taxpayers can reduce their tax burden or leverage the secondary market to assign credits. This integration provides a direct fiscal bridge between technical innovation and individual tax relief.

The Pennsylvania Personal Income Tax, as established under Article III of the Tax Reform Code of 1971, is a uniform tax imposed on the privilege of receiving eight specific classes of income by individuals and pass-through entities. In the context of the Research and Development (R&D) tax credit, Article III identifies the "qualified tax liability" that eligible taxpayers may offset to incentivize innovation and economic growth within the Commonwealth.

The legal structure of the Personal Income Tax (PIT) within Pennsylvania is fundamentally defined by the "Uniformity Clause" of the Commonwealth’s Constitution, which necessitates a flat-rate assessment across all taxpayers regardless of income level. Article III of the Tax Reform Code of 1971 provides the exhaustive statutory framework for this tax, detailing the definitions of residents, non-residents, and the specific categories of income that are subject to taxation. When juxtaposed with the Research and Development Tax Credit Law, codified as Article XVII-B of the same Code, the PIT serves as the primary target for credits earned by individuals, sole proprietors, and, most significantly, the owners of pass-through entities such as S corporations and partnerships. This integration creates a complex administrative ecosystem where the eligibility for a credit is determined at the entity or individual level based on qualified research expenses (QREs), but the actual fiscal benefit is realized as a direct reduction of the individual liability calculated under the mandates of Article III. For businesses operating within the Commonwealth, understanding this relationship is critical, as it bridges the gap between scientific activity and tax planning, allowing for the conversion of technical investment into tangible tax relief or, in some cases, liquid capital through the secondary assignment market.

Statutory Framework of Article III Personal Income Tax

The current iteration of Article III was enacted to provide a stable revenue base for the Commonwealth while adhering to constitutional requirements for tax uniformity. It classifies income into eight distinct categories, each with its own set of rules regarding allowable deductions and sourcing. For a taxpayer seeking to utilize an R&D tax credit, the first step is the accurate determination of "Income" as defined in Section 303, which includes compensation, net profits, gains, dividends, interest, rents, royalties, and gambling winnings.

Categories of Income and Taxability

The interaction between PIT and the R&D credit is most prominent in the "Net Profits" and "Net Gains" categories. Net profits represent the income derived from the operation of a business or profession, which is often the source of the expenditures that generate R&D credits. Conversely, net gains are relevant when a taxpayer sells or assigns an R&D credit, as the proceeds from such a sale are considered gain from the disposition of intangible property.

Article III Income Class Description and Legal Context Sourcing Relevance for R&D
Compensation Salaries, wages, and bonuses for services rendered within or outside PA by residents. Cannot be offset by R&D credit for withholding purposes.
Net Profits Income from business operations minus ordinary and necessary expenses. Primary liability class for sole proprietors and active partners.
Net Gains Profit from the sale or exchange of real or personal property. Vital for reporting the sale of tax credits as taxable events.
Dividends Distributions from corporate earnings and profits. Relevant for shareholders whose primary income is passive distributions.
Rents and Royalties Income from the use of property, patents, or copyrights. Often associated with the commercialization of R&D results.
Interest Earnings from debt instruments or savings. Generally passive; offset by credits if part of qualified liability.
Estates and Trusts Income received by beneficiaries from fiduciaries. Credits can pass through to beneficiaries of complex trusts.
Gambling Winnings Winnings from wagering and lotteries. Included in qualified liability but rarely the source of R&D credits.

The definition of a "taxpayer" under Article III extends to any individual, estate, or trust receiving these classes of income. However, in the context of the R&D credit, the definition is expanded by Article XVII-B to include any entity subject to tax under Article III, specifically naming shareholders of Pennsylvania S corporations as eligible participants. This ensures that the incentive for innovation is not limited to large C corporations but is accessible to the broader base of entrepreneurs who operate as pass-through entities.

Sourcing and Nexus for PIT

For residents of Pennsylvania, Article III imposes tax on all income regardless of its geographic source. For non-residents, the tax is limited to income earned from sources within the Commonwealth, which include ownership of property in PA, business activities conducted in PA, or services rendered in PA. This sourcing logic is mirrored in the R&D credit’s requirement that qualified research and development must be "conducted in this Commonwealth". The Department of Revenue determines the location of research based on the performance of services, the residence of the researchers, and the location where supplies are consumed.

The Research and Development Tax Credit Law (Article XVII-B)

The Research and Development Tax Credit Law was established to encourage taxpayers to increase their R&D expenditures within the Commonwealth. It provides a non-refundable tax credit that can be applied against the liability generated under Article III (PIT), Article IV (Corporate Net Income Tax), or Article VI (Capital Stock/Franchise Tax).

Core Definitions and Eligibility

Eligibility for the credit is predicated on the taxpayer incurring "Pennsylvania qualified research and development expenses" (PA QREs). The law adopts the federal definitions provided in Section 41 of the Internal Revenue Code but adds a strict geographic constraint: the research must occur within Pennsylvania.

Qualified research must satisfy the "Four-Part Test" to be eligible for inclusion in the credit calculation:

The research must be intended to discover information that eliminates technical uncertainty regarding the development or improvement of a product, process, or software. The taxpayer must engage in a process of experimentation involving the evaluation of alternatives through modeling, simulation, or trial and error. The research must fundamentally rely on the principles of engineering, physics, chemistry, biology, or computer science. The activity must have a "qualified purpose," meaning it aims to enhance the performance, reliability, quality, or functionality of a product or process.

The expenditures that constitute PA QREs include the wages paid to employees for performing qualified services, the cost of supplies used in the research, and the expenses associated with computer or cloud rental for research purposes. Payments to third-party contractors are also eligible, typically limited to 65% of the actual amount paid.

Credit Calculation Methodology

The Pennsylvania R&D credit is an incremental credit, meaning it rewards businesses that increase their R&D spending relative to their historical average. The calculation involves establishing a "Pennsylvania base amount," which serves as the threshold for the credit.

The mathematical determination of the credit follows this logic:

PA Base Amount = max(4-Year Average PA QREs, 0.5 × Current Year PA QREs)

Once the base amount is established, the "excess QREs" are calculated by subtracting the base amount from the current year's PA QREs. The credit rate is then applied to these excess expenditures.

Taxpayer Status Asset/Receipts Threshold Applicable Credit Rate
Qualified Small Business Net book value of assets < $5 million at start or end of year. 20% on excess QREs.
Large Business Net book value of assets >= $5 million. 10% on excess QREs.

A critical distinction exists for small businesses. Act 7 of 1997 and subsequent amendments have established a "double rate" for small firms to foster a supportive environment for startups. Furthermore, of the $60 million annual statewide cap, $12 million is explicitly reserved for small businesses to ensure they are not crowded out by large multinational corporations.

Revenue Office Guidance and Administrative Procedures

The Pennsylvania Department of Revenue (DOR) provides extensive guidance on the application process and the interaction between the R&D credit and the PIT liability under Article III. This guidance is disseminated through official bulletins, instructions for tax forms, and the myPATH online portal.

The myPATH Application Process

The application for the R&D tax credit is a time-sensitive process that requires electronic submission through myPATH. The application window opens on August 1 and closes on December 1 each year for expenditures incurred in the taxable year that ended in the prior calendar year. For example, expenses incurred during the 2023 calendar year must be reported via an application submitted by December 1, 2024.

The application requires detailed documentation, including:

Federal Form 6765: A copy of the federal R&D credit form as filed with the IRS. PA Form REV-545: The state-specific R&D credit calculation form. Project Descriptions: Detailed responses to technical questions for each Pennsylvania-based project, documenting how it meets the "Four-Part Test". Asset Verification: Small businesses must provide a balance sheet showing total assets are under $5 million to qualify for the 20% rate. Expenditure History: A breakdown of PA QREs for at least one and up to four prior years to establish the base amount.

The Department of Revenue has until May 1 of the following year to notify the applicant of their approved credit amount. If the program is oversubscribed—meaning the total tentative credits requested exceed the $60 million cap—the DOR will prorate the awards. In the 2024 award cycle, non-small businesses saw their awards prorated to 41.1% of their tentative requests, while small businesses in many years receive 100% of their requests due to the set-aside.

Tax Clearance and Compliance Requirements

Under Act 43 of 2017, the DOR is authorized to perform "tax clearances" on all applicants prior to awarding any credit. An applicant must be in full compliance with all Pennsylvania tax reporting and payment obligations. This includes the entity’s own taxes as well as the taxes of any individual or entity with a 20% or greater ownership interest in the applicant. If an applicant is deemed non-compliant, the credit will be denied, emphasizing the importance of Article III PIT compliance for individuals who own innovative businesses.

Pass-Through Entity Dynamics and PIT Application

For most individuals, the R&D credit is accessed through their ownership in a pass-through entity (PTE), such as an S corporation, partnership, or LLC. The mechanism by which the credit travels from the business to the individual’s Article III PIT return is governed by specific "pass-through" rules.

Distribution and Irrevocable Election

When a PTE is awarded an R&D tax credit, it must first apply the credit against its own corporate tax liability, if any, for the year the credit is granted. Any remaining credit can then be passed through to the owners in proportion to their share of the entity's distributive income.

The election to pass through the credit is irrevocable. To finalize the distribution, the entity must notify the DOR by providing a request on entity letterhead or a claim form that includes:

The total amount of credit to be distributed. The name, address, and Social Security Number (or EIN) of each owner. The specific amount allocated to each owner.

This statement must be signed by an authorized representative and submitted to the Office of Economic Development before the owners file their individual tax returns.

Reporting on PA-40 Schedule OC

Individuals receiving a pass-through credit report it on their personal income tax return using PA-40 Schedule OC. The credit can be used to offset up to 100% of the individual’s tax liability calculated under Article III.

Schedule OC Field Guidance for PIT Reporting
Credit Description Code Use "PT" for credits received from a pass-through entity; "CY" for current year credits awarded directly.
Awardee Tax ID Number Enter the EIN of the pass-through entity that originally received the credit award.
Amount Utilized Enter the portion of the credit being used to offset the current year's liability.

If an individual is a shareholder of a Pennsylvania S corporation or a partner in a partnership, they must also ensure the credit matches the amount reported on their PA Schedule RK-1 (for residents) or PA Schedule NRK-1 (for non-residents). The DOR warns that simply listing the credit on the RK-1 is insufficient; the formal pass-through notification from the entity to the DOR is mandatory for the credit to be validated at the individual level.

The Secondary Market: Sale and Assignment of R&D Credits

One of the most valuable features of the Pennsylvania R&D tax credit is its transferability. Businesses that cannot use their credits—often because they are pre-revenue or have insufficient PIT/CNIT liability—can sell them on the open market.

Guidelines for Sellers and Assignors

A taxpayer may apply to the Department of Community and Economic Development (DCED) for approval to assign their eligible R&D tax credits to a "buyer". To be eligible, the seller must:

Possess credits that were approved by the DOR at least one year prior to the proposed assignment. Have no collectible Pennsylvania tax liability against which the credits could be offset. Ensure the credits are within their 15-year maximum lifetime.

The sale of a credit is considered a taxable transaction for PIT purposes. The seller must report the proceeds as a gain on the sale of property on PA-40 Schedule D. Because the credit is awarded based on expenses already included in the return, the cost basis for the credit is typically $0, meaning the entire sales price (minus broker commissions) is taxable as a gain.

Guidelines for Buyers and Assignees

Buyers of R&D credits use them to offset their own PIT or corporate liabilities. However, buyers face more restrictive rules than original awardees:

75% Offset Limit: A buyer may only use the purchased credits to offset up to 75% of their qualified tax liability for the year. No Carryover: Unlike the original seller (who has a 15-year carryforward), a buyer must use the credit in the taxable year in which the assignment is approved by the DCED. If not used, the credit expires. No Resale: Credits may only be assigned once; a buyer cannot re-assign or resell them to another party.

Feature Original Awardee (Seller) Purchaser (Buyer)
Offset Limit 100% of qualified liability. 75% of qualified liability.
Carryforward 15 years. None; must use in year of purchase.
Carryback Not allowed. Not allowed.
Assignment Can sell to one or more buyers. Cannot re-assign or resell.

Comparative Analysis: Federal vs. Pennsylvania R&D Credits

While the Pennsylvania R&D credit adopts many federal concepts, the intersection with PIT introduces several unique state-specific nuances.

Geographic and Calculation Differences

The most fundamental difference is the geographic scope. The federal credit applies to research conducted anywhere in the United States, whereas the Pennsylvania credit is strictly limited to activity within the state's borders. This necessitates a rigorous internal accounting system to isolate PA-specific wages, supplies, and contractor costs from general R&D spending.

Feature Federal R&D Credit (IRC § 41) Pennsylvania R&D Credit (Art. XVII-B)
Base Rate 20% (Traditional) or 14% (ASC). 10% (Large) or 20% (Small Biz).
Geographic Scope United States-based research. Pennsylvania-based research.
Carryforward 20 years. 15 years.
Refundability Non-refundable (unless payroll tax election for startups). Non-refundable (but sellable for cash).
Application Against federal income tax. Against PIT (Art. III) or CNIT (Art. IV).
The Impact of the Tax Cuts and Jobs Act (TCJA)

The federal TCJA of 2017 introduced a requirement for businesses to capitalize and amortize R&D expenses over five years starting in 2022, replacing the immediate expensing option under IRC § 174. However, Pennsylvania’s PIT guidance clarifies that Article III does not incorporate this federal amortization requirement. For Pennsylvania personal income tax purposes, costs associated with R&D may still be expensed or depreciated based on the nature of the expenditure under state law. This decoupling means that a taxpayer’s "Net Profits" on their PA-40 may differ significantly from their federal taxable income regarding R&D costs.

Detailed Practical Example: BioTech Innovations S Corp

To illustrate the application of Article III and the R&D tax credit, consider the following scenario involving a small Pennsylvania technology firm and its individual owners.

Phase 1: Expenditure and Credit Calculation

BioTech Innovations is a Pennsylvania S corporation with $3 million in assets, qualifying it as a "Small Business". During the 2023 calendar year, the company conducted qualified research in a lab in Philadelphia to develop a new diagnostic kit.

2023 PA QREs:

Wages for research staff: $300,000

Supplies consumed: $50,000

Contract research payments: $100,000 (of which 65% is eligible = $65,000)

Total: $415,000

Historical PA QREs:

2022: $300,000

2021: $250,000

2020: $200,000

2019: $150,000

4-Year Average: $225,000

Credit Determination:

Base Amount: $225,000 (greater of $225,000 average or $207,500 half-current)

Excess QREs: $415,000 - $225,000 = $190,000

Tentative Credit: $190,000 × 20% = $38,000

The company submits its application via myPATH by December 1, 2024. Because it is a small business and timely filed, it receives an award letter for the full $38,000 on May 1, 2025.

Phase 2: Pass-Through to Shareholders

BioTech Innovations has two equal shareholders, Sarah and John, both residents of Pennsylvania. The company has no corporate tax liability and elects to pass the credit through.

The company emails the DOR the pass-through notification form by June 1, 2025.

Sarah and John each receive a Schedule RK-1 showing a distributive share of $19,000 in R&D tax credits.

Phase 3: PIT Filing for Shareholders

For the 2024 tax year (the year the credit is utilized), Sarah has the following Article III income:

Net Profits (from the S Corp): $500,000

Dividends: $10,000

Total PIT Liability ($510,000 × 3.07%): $15,657

Sarah files her PA-40 and includes Schedule OC.

She enters Code "PT" and the S Corp's EIN.

She applies $15,657 of her $19,000 credit to reduce her liability to $0.

The remaining $3,343 is carried forward for up to 15 years to offset future Article III liability.

Phase 4: Secondary Market Transaction (Alternative)

If John decides he does not want to carry forward his $19,000 credit and would prefer cash, he can wait until one year after the award (May 2026) and apply to the DCED to sell the credit.

John sells the $19,000 credit to a buyer for 90 cents on the dollar ($17,100).

John must report the $17,100 on his PA-40 Schedule D as a gain from the sale of intangible property.

Since his cost basis is $0, he pays 3.07% tax on the $17,100 gain ($525).

The buyer uses the $19,000 credit to offset their own PIT, but only up to 75% of their total liability for that year.

Compliance, Audits, and Fraud Prevention

The administration of the R&D credit is subject to rigorous oversight by both the DOR and the Office of the Attorney General. A 2019 Grand Jury investigation exposed "sham businesses" created solely to generate undeserved credits, leading to increased scrutiny of all applications.

Audit Retention and Verification

Taxpayers are required to maintain all records relating to their R&D credit application for at least five years after the application is submitted. The DOR may request additional information via mail or conduct an on-site audit at the physical address where the records are maintained.

Common audit focus areas include:

Wages vs. Subcontractors: Auditors verify that expenditures listed as "direct wages" are supported by PA-W3 withholding records and that 1099-MISC/NEC forms are issued for subcontracted labor. Elimination of Uncertainty: The technical narrative must provide specific engineering or scientific details. Vague or marketing-oriented descriptions will result in denial of the credit. Sourcing of Materials: Supplies must be consumed within Pennsylvania. Invoices showing out-of-state delivery points for R&D materials are often flagged for exclusion.

Appeals Process (Act 25 of 2021)

Prior to 2021, taxpayers had limited recourse if an R&D credit was denied. Act 25 of 2021 established a formal appeals process for taxpayers, brokers, and the DOR. Taxpayers now have the right to appeal a determination of non-compliance, a proration calculation, or a denial based on technical eligibility to the Board of Appeals. This provides an essential layer of due process for individuals whose Article III PIT liability is impacted by administrative decisions regarding their R&D credits.

Restricted Tax Credit Bulletin 2024-01: Application of Credits

The Department of Revenue’s Restricted Tax Credit Bulletin 2024-01 provides specific guidance on how credits are applied to taxpayer accounts to ensure maximum utilization. The general rule is "FIFO" (First-In, First-Out), where the oldest credits are applied first to prevent them from expiring after the 15-year carryforward period.

Example of Multi-Year Application

Consider a calendar-year taxpayer with a recurring R&D credit and fluctuating PIT liability.

Tax Year Credit Approved PIT Liability Credit Used Carryforward Remaining
Year 1 $2,500 $1,500 $1,500 $1,000 (from Yr 1)
Year 2 $4,000 $2,700 $2,700 $1,300 (from Yr 2) + $1,000 (from Yr 1)
Year 3 $1,000 $2,600 $2,600 $0 (Year 1 & 3 fully used; $200 Year 2 left)

In Year 3, the taxpayer uses the current year credit of $1,000 first, then the $1,000 carryforward from Year 1, and finally $600 of the Year 2 carryforward to satisfy the $2,600 liability. This systematic application ensures that the oldest credits (Year 1) are exhausted before they reach their expiration date.

Estimated Payments and Interest

For individuals required to make estimated PIT payments, restricted credits like the R&D credit can be used to satisfy these obligations. However, there is a catch: for purchased or assigned credits, the buyer cannot reduce their estimated payments for periods before the credit is officially in their account. If a buyer reduces their estimated payments prematurely, they may be subject to "estimated enforcement interest" on the underpayment until the date the credit assignment is approved.

Final Thoughts

The intersection of Article III Personal Income Tax and the Research and Development Tax Credit represents a sophisticated regulatory framework designed to balance fiscal oversight with economic stimulus. For the individual taxpayer, the R&D credit is not merely a technical incentive for the business entity but a direct mechanism for reducing personal tax exposure on distributive income.

The key to successfully navigating this framework lies in proactive compliance and meticulous documentation. Taxpayers must recognize that the "tax clearance" requirement makes Article III PIT compliance a prerequisite for receiving any R&D benefits. Furthermore, the move to a December 1 application deadline and the utilization of the myPATH portal require businesses to align their tax planning cycles with state administrative timelines.

For small businesses, the 20% credit rate and the $12 million set-aside provide a significant competitive advantage, provided they can substantiate their asset levels and technical technical processes. For pre-revenue innovators, the secondary market remains a vital lifeline, offering non-dilutive capital that can be reinvested into further research. However, the taxable nature of the sale proceeds—and the 75% offset limit for buyers—must be factored into the valuation of these credits.

As Pennsylvania continues to emphasize technology and innovation sectors, the R&D tax credit will likely remain a permanent fixture of the Tax Reform Code. By understanding the nuances of Article III PIT and the administrative guidance provided by the Department of Revenue, taxpayers can effectively leverage these incentives to drive growth and sustainability in the Commonwealth’s innovation economy.

Who We Are:

Swanson Reed is one of the largest Specialist R&D Tax Credit advisory firm in the United States. With offices nationwide, we are one of the only firms globally to exclusively provide R&D Tax Credit consulting services to our clients. We have been exclusively providing R&D Tax Credit claim preparation and audit compliance solutions for over 30 years. Swanson Reed hosts daily free webinars and provides free IRS CE and CPE credits for CPAs.

Are you eligible?

R&D Tax Credit Eligibility AI Tool

Why choose us?

R&D tax credit

Pass an Audit?

R&D tax credit

What is the R&D Tax Credit?

The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.

Never miss a deadline again

R&D tax credit

Stay up to date on IRS processes

Discover R&D in your industry

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/

R&D Tax Credit Training for CPAs

R&D tax credit

Upcoming Webinars

R&D Tax Credit Training for CFPs

bigstock Image of two young businessmen 521093561 300x200

Upcoming Webinars

R&D Tax Credit Training for SMBs

water tech

Upcoming Webinars
Contact Us

Send us a message and we will be in touch shortly!

Start typing and press Enter to search